Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1109 | 1016 | 1114 | 1166 | 1496 | 2533 |
Fund Return | 10.9% | 1.55% | 11.36% | 5.25% | 8.39% | 9.74% |
Place in category | 1657 | 1716 | 1726 | 1187 | 928 | 218 |
% in Category | 95 | 95 | 98 | 79 | 74 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr F | 7.45B | 12.14 | 6.55 | 11.10 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.45B | 12.15 | 6.55 | 11.10 | ||
Manulife Glbl Eq Cl Sr T6 | 7.45B | 10.89 | 5.25 | 9.73 | ||
Manulife Div incm Fd Sr Adv | 7.24B | 18.71 | 2.98 | 9.01 | ||
Manulife Div incm Fd Sr F | 7.24B | 19.93 | 4.13 | 10.23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.18B | 55.54 | 14.87 | - | ||
Mawer Global Equity | 13.9B | 11.93 | 6.20 | 10.88 | ||
Capital Group Glbal Equity Fd F CAD | 14.19B | 27.39 | 5.28 | 11.77 | ||
Capital Group Glbal Equity Fd A CAD | 14.19B | 26.11 | 4.12 | 10.53 | ||
Capital Group Glbal Equity Fd D CAD | 14.19B | 27.03 | 4.93 | 11.29 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.28 | 102.50 | +0.05% | |
Marsh McLennan | US5717481023 | 5.03 | 214.04 | +0.88% | |
UnitedHealth | US91324P1021 | 4.17 | 506.10 | -0.05% | |
Microsoft | US5949181045 | 4.13 | 439.33 | +0.94% | |
Alimentation Couche Tard | CA01626P1484 | 3.67 | 80.59 | +0.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review